Article info

Download PDFPDF
Letter
Pamidronate administration may result in anaemia in children with osteogenesis imperfecta

Authors

  1. Correspondence to Dr Izabela Michałus, Department of Pediatrics, Neonates Pathology and Bone Metabolic Diseases, Medical University of Lodz, 36/50 Sporna Street, 91-738, Lodz, Poland; izabela.michalus{at}gmail.com
View Full Text

Citation

Michałus I, Nowicka Z, Pietras WA, et al
Pamidronate administration may result in anaemia in children with osteogenesis imperfecta

Publication history

  • Accepted May 31, 2019
  • First published June 26, 2019.
Online issue publication 
August 16, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.